EICHOR
● Active Not Recruiting
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
Condition: Solid Tumor, Adult · Pancreatic Cancer · Virus-associated Tumors · Sponsor: Institut Bergonié
About this study
Basket trial concept to independently and simultaneously assess the effects of the association of atezolizumab + BDB001 + radiotherapy in multiple solid tumors.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (11)
| Institut Bergonié | Bordeaux, France | — |
| Chu Brest | Brest, France | — |
| Centre François Baclesse | Caen, France | — |
| Centre Georges François Leclerc | Dijon, France | — |
| Centre Oscar Lambret | Lille, France | — |
| Hôpital La Timone | Marseille, France | — |
| Institut Paoli Calmettes | Marseille, France | — |
| Institut Curie | Paris, France | — |
| CHU Poitiers | Poitiers, France | — |
| Centre Eugène Marquis | Rennes, France | — |
| IUCT Oncopôle | Toulouse, France | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03915678